In vitro and in vivo model systems to study microbial biofilm formation

被引：347

作者：

Coenye, Tom ^{[1
]}

Nelis, Hans J. ^{[1
]}

机构：

[1] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium

来源：

JOURNAL OF MICROBIOLOGICAL METHODS | 2010年 / 83卷 / 02期

关键词：

Biofilm; Model system; Animal model; CENTRAL VENOUS CATHETER; CANDIDA-ALBICANS BIOFILM; FOREIGN-BODY INFECTION; PSEUDOMONAS-AERUGINOSA BIOFILM; URINARY-TRACT-INFECTION; MODIFIED ROBBINS DEVICE; POLYSACCHARIDE INTERCELLULAR ADHESIN/HEMAGGLUTININ; STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS; COAGULASE-NEGATIVE STAPHYLOCOCCI; PERITONEAL-DIALYSIS CATHETERS;

D O I：

10.1016/j.mimet.2010.08.018

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Biofilm formation is often considered the underlying reason why treatment with an antimicrobial agent fails and as an estimated 65-80% of all human infections is thought to be biofilm-related, this presents a serious challenge. Biofilm model systems are essential to gain a better understanding of the mechanisms involved in biofilm formation and resistance. In this review a comprehensive overview of various in vitro and in vivo systems is presented, and their advantages and disadvantages are discussed. (C) 2010 Elsevier B.V. All rights reserved.

引用

页码：89 / 105

页数：17

共 345 条

[1] Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis [J].

Aaron, SD ;

Ferris, W ;

Ramotar, K ;

Vandemheen, K ;

Chan, F ;

Saginur, R .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4172-4179

[2]

Adams H, 2002, AM J DENT, V15, p12B

[3] Inhibition of Staphylococcus aureus Biofilms by a Novel Antibacterial Envelope for Use with Implantable Cardiac Devices [J].

Agostinho, Alessandra ;

James, Garth ;

Wazni, Oussama ;

Citron, Mark ;

Wilkoff, Bruce D. .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (03) :193-198

[4] Investigating the suitability of the Calgary Biofilm Device for assessing the antimicrobial efficacy of new agents [J].

Ali, Laila ;

Khambaty, Farukh ;

Diachenko, Gregory .

BIORESOURCE TECHNOLOGY, 2006, 97 (15) :1887-1893

[5] Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro [J].

Amorena, B ;

Gracia, E ;

Monzón, M ;

Leiva, J ;

Oteiza, C ;

Pérez, M ;

Alabart, JL ;

Hernández-Yago, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :43-55

[6]

AN YH, 2003, MED IMPLICATIONS BIO, P59

[7] Development and characterization of an in vivo central venous catheter Candida albicans biofilm model [J].

Andes, D ;

Nett, J ;

Oschel, P ;

Albrecht, R ;

Marchillo, K ;

Pitula, A .

INFECTION AND IMMUNITY, 2004, 72 (10) :6023-6031

[8]

[Anonymous], BIOFILM LAB STEP STE

[9] Eradication of Enterococcus faecalis Biofilms by Cetrimide and Chlorhexidine [J].

Arias-Moliz, Maria Teresa ;

Maria Ferrer-Luque, Carmen ;

Paloma Gonzalez-Rodriguez, Maria ;

Jose Valderrama, Mariano ;

Baca, Pilar .

JOURNAL OF ENDODONTICS, 2010, 36 (01) :87-90

[10] New Method Showing the Influence of Matrix Components in Leuconostoc mesenteroides Biofilm Formation [J].

Badel, S. ;

Laroche, C. ;

Gardarin, C. ;

Bernardi, T. ;

Michaud, P. .

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2008, 151 (2-3) :364-370

← 1 2 3 4 5 6 7 8 9 10 →